Scientific Bioprocessing
Private Company
Total funding raised: $6.2M
Overview
Scientific Bioprocessing is a private instrumentation company that has developed the innovative DOTS Platform, a suite of hardware sensors and software designed to bring bioreactor-like data and control capabilities to traditional shake flasks. This addresses a key bottleneck in bioprocess development by providing high-resolution, real-time data from early-stage screening and optimization experiments, improving the predictability and efficiency of scaling to manufacturing bioreactors. The company serves the biologics manufacturing and process development sectors, with products targeting parameters such as dissolved oxygen, biomass, and pH, and enabling automated feeding. Its value proposition is reducing development timelines and costs for customers in pharmaceuticals, industrial biotechnology, and synthetic biology.
Technology Platform
The DOTS Platform: A suite of hardware sensors (for biomass, dissolved oxygen, pH) and software that transforms standard shake flasks into instrumented, data-rich cultivation systems. It enables real-time monitoring and control (e.g., automated feeding) of bioprocesses at the shake flask scale.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
SBI competes in the bioprocess analytical instrumentation space. Its direct niche competition includes specialized sensor companies, but its primary competition is the entrenched practice of manual sampling. Larger broad-line players like Sartorius, Thermo Fisher, and Merck (with its BioContinuum™ portfolio) offer advanced sensor solutions, but often focus on bioreactor scales, leaving the shake flask niche less saturated.